Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Giorgadze TA, Scognamiglio T, Yang GC. Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations. Cancer Cytopathol. 2015;123(2):71-81.

Heymann JJ, Halligan AM, Hoda SA, Facey KE, Hoda RS. Fine needle aspiration of breast masses in pregnant and lactating women: experience with 28 cases emphasizing Thinprep findings. Diagn Cytopathol. 2015;43(3):188-94.

Ginter PS, Scognamiglio T. Papillary thyroid carcinoma with nodular fasciitis-like stroma: a usual entity with distinctive morphology. Int J Surg Pathol. 2015;23(4):305-7.

Greenblatt MB, Kim J-, Oh H, Park KH, Choo M-, Sano Y, et al. p38α MAPK is required for tooth morphogenesis and enamel secretion. J Biol Chem. 2015;290(1):284-95.

Inghirami G, Chan WC, Pileri S. Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications. Immunol Rev. 2015;263(1):124-59.

Ozerdem U, Hoda SA. Endosalpingiosis of axillary sentinel lymph node: a mimic of metastatic breast carcinoma. Breast J. 2015;21(2):194-5.

Klingler S, Guo B, Yao J, Yan H, Zhang L, Vaseva AV, et al. Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms. Cancer Res. 2015;75(10):2109-19.

Elia AR, Circosta P, Sangiolo D, Bonini C, Gammaitoni L, Mastaglio S, et al. Cytokine-induced killer cells engineered with exogenous T-cell receptors directed against melanoma antigens: enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition. Hum Gene Ther. 2015;26(4):220-31.

Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, et al. A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. Clin Genitourin Cancer. 2015;13(2):113-23.

Zhao Z, Chen C-, Rillahan CD, Shen R, Kitzing T, McNerney ME, et al. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet. 2015;47(5):539-43.